Febrile neutropenia rates with adjuvant docetaxel and cyclophosphamide chemotherapy in early breast cancer: discrepancy between published reports and community practice-an updated analysis

被引：19
作者：
Younus, J. [1 ]
Vandenberg, T. [1 ]
Jawaid, M. [2 ]
Jawaid, M. A. [3 ]
机构：
[1] London Reg Canc Program, Dept Med Oncol, London, ON N6A 4L6, Canada
[2] Univ Western Ontario, Schulich Sch Med, London, ON, Canada
[3] Univ Western Ontario, Dept Social Sci, London, ON, Canada
来源：
CURRENT ONCOLOGY | 2012年 / 19卷 / 06期
关键词：
Febrile neutropenia; breast cancer; adjuvant chemotherapy; RANDOMIZED-TRIALS; METAANALYSIS; DOXORUBICIN; OUTCOMES; OLDER;
D O I：
10.3747/co.19.1174
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：332 / 334
页数：3
相关论文
共 47 条
[41]   The Efficacy Research of Prophylactic PEG-rhG-CSF in Preventing Neutropenia in Early-Stage Breast Cancer Patients Treated With Docetaxel-Based Chemotherapy: A Retrospective Analysis [J].
Xing, Xueting ;
Ding, Weijie ;
Tang, Yongzhe ;
Zhang, Jin ;
Liu, Yamin ;
Ning, Junhong ;
Wang, Jie ;
Zhang, Xiaoqing .
CLINICAL THERAPEUTICS, 2025, 47 (01) :21-28
[42]   Dose-Dense Docetaxel versus Weekly Paclitaxel following Dose-Dense Epirubicin and Cyclophosphamide as Adjuvant Chemotherapy in Node-Positive Breast Cancer Patients: A Retrospective Cohort Analysis [J].
Khoshroo, Sara ;
Sandoughdaran, Saleh ;
Sabetrasekh, Parisa ;
Hajian, Parastoo ;
Bikdeli, Pegah ;
Sabetrasekh, Parto ;
Nasrollahi, Fatemeh ;
Yeganeh, Ladan Mohammadi ;
Naeini, Sepideh Jafari ;
Mirzaei, Hamid Reza .
INTERNATIONAL JOURNAL OF BREAST CANCER, 2021, 2021
[43]   Efficacy of same-day versus next-day administration of pegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients receiving dose-dense doxorubicin and cyclophosphamide: A retrospective multi-site analysis [J].
Hobbs, Jacob ;
Lowe, Jan ;
Ferdinand, Abigale ;
Shook, Anna ;
Beck, Bradley ;
Blais, Danielle ;
Borchardt, Cole ;
Xu, Bing .
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (08) :1853-1861
[44]   Sequential vs concurrent epirubicin and docetaxel as adjuvant chemotherapy for high-risk, node-negative, early breast cancer: an interim analysis of a randomised phase III study from the Hellenic Oncology Research Group [J].
Dimitrios Mavroudis ;
Emmanouil Saloustros ;
Ioannis Boukovinas ;
Pavlos Papakotoulas ;
Stylianos Kakolyris ;
Nikolaos Ziras ;
Charalampos Christophylakis ;
Nikolaos Kentepozidis ;
Georgios Fountzilas ;
Georgios Rigas ;
Ioannis Varthalitis ;
Konstantinos Kalbakis ;
Sofia Agelaki ;
Dora Hatzidaki ;
Vasilios Georgoulias .
British Journal of Cancer, 2017, 117 :164-170
[45]   Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08-10 trial [J].
Gullo, Giuseppe ;
Eustace, Alex J. ;
Canonici, Alexandra ;
Collins, Denis M. ;
Kennedy, Michael J. ;
Grogan, Liam ;
Breathhnach, Oscar ;
McCaffrey, John ;
Keane, Maccon ;
Martin, Michael J. ;
Gupta, Rajnish ;
Leonard, Gregory ;
O'Connor, Miriam ;
Calvert, Paula M. ;
Donnellan, Paul ;
Walshe, Janice ;
McDermott, Enda ;
Scott, Kathleen ;
Hernando, Andres ;
Parker, Imelda ;
Murray, David W. ;
O'Farrell, Alice C. ;
Maratha, Ashwini ;
Dicker, Patrick ;
Rafferty, Mairin ;
Murphy, Verena ;
O'Donovan, Norma ;
Gallagher, William M. ;
Ky, Bonnie ;
Tryfonopoulos, Dimitrios ;
Moulton, Brian ;
Byrne, Annette T. ;
Crown, John .
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
[46]   Neoadjuvant, anthracycline-free chemotherapy with carboplatin and docetaxel in triple-negative, early-stage breast cancer: a multicentric analysis of rates of pathologic complete response and survival [J].
Kern, Peter ;
Kalisch, Anne ;
von Minckwitz, Gunter ;
Puetter, Carolin ;
Kolberg, Hans-Christian ;
Pott, Dirk ;
Kurbacher, Christian ;
Rezai, Mahdi ;
Kimmig, Rainer .
JOURNAL OF CHEMOTHERAPY, 2016, 28 (03) :210-217
[47]   Neoadjuvant, Anthracycline-Free Chemotherapy with Carboplatin and Docetaxel in Triple-Negative, Early-Stage Breast Cancer: A Multicentric Analysis of Feasibility and Rates of Pathologic Complete Response [J].
Kern, Peter ;
Kalisch, Anne ;
Kolberg, Hans-Christian ;
Kimmig, Rainer ;
Otterbach, Friederich ;
von Minckwitz, Gunter ;
Sikov, William M. ;
Pott, Dirk ;
Kurbacher, Christian .
CHEMOTHERAPY, 2013, 59 (05) :387-394
12345